Sera Prognostics, Inc.
Status: Publicly traded
Direct answer
Sera Prognostics, Inc. is publicly traded on NASDAQ under the ticker SERA.
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is...
Can you invest in Sera Prognostics, Inc.?
Yes. Sera Prognostics, Inc. trades publicly on NASDAQ as SERA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Sera Prognostics, Inc.
Detailed equity research is provided by MarketSnap.